This decommissioned ERA site remains active temporarily to support our final migration steps to https://ualberta.scholaris.ca, ERA's new home. All new collections and items, including Spring 2025 theses, are at that site. For assistance, please contact erahelp@ualberta.ca.
Search
Skip to Search Results-
Osteosarcoma (OS) progression is associated with increased nuclear levels and transcriptional activity of Active-β-catenin (ABC)
DownloadSpring 2019
Osteosarcoma (OS) is an aggressive primary bone malignancy having peak incidence in children and young adults <25 years of age. Outcome remains poor for most patients with metastatic disease which develops in 1 of every 5 cases. However, despite the use of multimodal chemotherapeutic and surgical...
-
Spring 2016
Osteosarcoma (OS) is the most common primary bone malignancy with a high incidence in children and adolescents. Current treatment strategies (surgery and adjuvant chemotherapy) has improved the overall survival rate of patients with primary OS. However, the survival rate of patients with...